Erythromycin ointment
Function and Efficacy
Erythromycin is a macrolide antibiotic, which has antibacterial activity against Staphylococcus, various groups of Streptococcus and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.
Ingredients
Each vial of this product contains 80,000 units of erythromycin as the main ingredient and yellow vaseline as the auxiliary material.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| ErythromycinIngredients |
Erythromycin is a macrolide antibiotic, which has antibacterial activity against Staphylococcus, various groups of Streptococcus and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide. More |
114-07-8 | 43 |
Appearance
This product is a white, light yellow or yellow ointment.
Indication
This product is an over-the-counter drug for dermatology. It is used for suppurative skin diseases such as impetigo, small-area burns, ulcer surface infections and acne vulgaris.
Usage and Dosage
For topical use, take an appropriate amount of this product and apply it to the affected area, twice a day.
Adverse Reactions
Irritation and allergic reactions may occur occasionally.
Precautions
It is contraindicated in patients who are allergic to erythromycin.
Special Population Medication
Precautions for children: Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly:
Drug Interactions
1. It has antagonistic effects with chloramphenicol and lincomycin, so avoid using it together. 2. If used with other drugs at the same time, drug interactions may occur. Please consult your doctor or pharmacist for details.
Storage
Keep tightly closed in a cool, dry place.
Packaging Specification
0.01
Manufacturer
Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
-
Founded in:
1992-03-31 -
Address:
No. 789, Xinluo Street, Jinan High-tech Development Zone -
Tax NO.:
913701006140705563 -
Registered Funds:
90 million yuan -
Website:
-
Email: